Weave’s Brandon Rice on Rebuilding Drug Regulation with AI
About this episode
Brandon Rice discusses the modernization of drug regulation through AI and the challenges involved in the process.
Brandon Rice believes that improving health care sometimes means improving the systems behind it. Through his work at Weave, he focuses on modernizing the regulatory infrastructure that helps bring new medicines to market. He discusses the challenge of organizing scientific knowledge, communicating with regulators, and navigating processes that can span more than a decade. His vision is that AI can reduce administrative burden while preserving the rigor required for patient safety and scientific progress. Transcript.
More episodes of NEJM AI Grand Rounds
Explore listener stats, chart rankings, contacts and more on the NEJM AI Grand Rounds podcast page.